ELVN
Price
$16.53
Change
+$0.46 (+2.86%)
Updated
Apr 17, 04:59 PM (EDT)
Capitalization
787.5M
21 days until earnings call
MRUS
Price
$43.02
Change
+$1.11 (+2.65%)
Updated
Apr 17, 04:59 PM (EDT)
Capitalization
2.9B
26 days until earnings call
Ad is loading...

ELVN vs MRUS

Header iconELVN vs MRUS Comparison
Open Charts ELVN vs MRUSBanner chart's image
Enliven Therapeutics
Price$16.53
Change+$0.46 (+2.86%)
Volume$1.92K
Capitalization787.5M
Merus
Price$43.02
Change+$1.11 (+2.65%)
Volume$5.26K
Capitalization2.9B
ELVN vs MRUS Comparison Chart
Loading...
ELVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ELVN vs. MRUS commentary
Apr 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELVN is a Hold and MRUS is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 18, 2025
Stock price -- (ELVN: $16.07 vs. MRUS: $41.91)
Brand notoriety: ELVN and MRUS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ELVN: 86% vs. MRUS: 147%
Market capitalization -- ELVN: $787.5M vs. MRUS: $2.9B
ELVN [@Biotechnology] is valued at $787.5M. MRUS’s [@Biotechnology] market capitalization is $2.9B. The market cap for tickers in the [@Biotechnology] industry ranges from $287.04B to $0. The average market capitalization across the [@Biotechnology] industry is $2.08B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELVN’s FA Score shows that 0 FA rating(s) are green whileMRUS’s FA Score has 1 green FA rating(s).

  • ELVN’s FA Score: 0 green, 5 red.
  • MRUS’s FA Score: 1 green, 4 red.
According to our system of comparison, MRUS is a better buy in the long-term than ELVN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELVN’s TA Score shows that 4 TA indicator(s) are bullish while MRUS’s TA Score has 4 bullish TA indicator(s).

  • ELVN’s TA Score: 4 bullish, 5 bearish.
  • MRUS’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ELVN is a better buy in the short-term than MRUS.

Price Growth

ELVN (@Biotechnology) experienced а -2.72% price change this week, while MRUS (@Biotechnology) price change was +5.94% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.07%. For the same industry, the average monthly price growth was -13.37%, and the average quarterly price growth was -24.84%.

Reported Earning Dates

ELVN is expected to report earnings on Aug 07, 2025.

MRUS is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+7.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MRUS($2.9B) has a higher market cap than ELVN($788M). MRUS YTD gains are higher at: -0.333 vs. ELVN (-28.578). ELVN has higher annual earnings (EBITDA): -104.24M vs. MRUS (-269.6M). MRUS has more cash in the bank: 537M vs. ELVN (313M). ELVN has less debt than MRUS: ELVN (0) vs MRUS (9.91M). MRUS has higher revenues than ELVN: MRUS (36.1M) vs ELVN (0).
ELVNMRUSELVN / MRUS
Capitalization788M2.9B27%
EBITDA-104.24M-269.6M39%
Gain YTD-28.578-0.3338,584%
P/E RatioN/AN/A-
Revenue036.1M-
Total Cash313M537M58%
Total Debt09.91M-
FUNDAMENTALS RATINGS
MRUS: Fundamental Ratings
MRUS
OUTLOOK RATING
1..100
64
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
PROFIT vs RISK RATING
1..100
32
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
56
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ELVNMRUS
RSI
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
75%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 3 days ago
84%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 10 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 2 days ago
72%
View a ticker or compare two or three
Ad is loading...
ELVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X84033.870000364.875000
+0.44%
Bitcoin cryptocurrency
GME26.25-0.45
-1.69%
GameStop Corp
SPY525.66-11.95
-2.22%
SPDR® S&P 500® ETF
AAPL194.27-7.87
-3.89%
Apple
TSLA241.55-12.56
-4.94%
Tesla

ELVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELVN has been loosely correlated with ERAS. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ELVN jumps, then ERAS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELVN
1D Price
Change %
ELVN100%
-5.75%
ERAS - ELVN
50%
Loosely correlated
-1.68%
APGE - ELVN
48%
Loosely correlated
-2.47%
CRNX - ELVN
48%
Loosely correlated
-0.27%
KYMR - ELVN
47%
Loosely correlated
-1.73%
DNLI - ELVN
46%
Loosely correlated
-4.71%
More

MRUS and

Correlation & Price change

A.I.dvisor indicates that over the last year, MRUS has been loosely correlated with CGON. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if MRUS jumps, then CGON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRUS
1D Price
Change %
MRUS100%
-3.03%
CGON - MRUS
44%
Loosely correlated
+0.55%
RCKT - MRUS
38%
Loosely correlated
-5.82%
IMTX - MRUS
38%
Loosely correlated
-5.95%
XENE - MRUS
38%
Loosely correlated
+2.27%
KRYS - MRUS
37%
Loosely correlated
-2.62%
More